Functionally defined therapeutic targets in diffuse intrinsic pontine glioma

Grasso, Catherine S, Tang, Yujie, Truffaux, Nathalene, Berlow, Noah E, Liu, Lining, Debily, Marie-Anne, Quist, Michael J, Davis, Lara E +32 more·2015·Nature Medicine

DOI 10.1038/nm.3855

Cited by (686)

Items 101–200 of 686

BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology
Ganesh M. Shankar, Nina Lelic, Corey M. Gill, Aaron R. Thorner, Paul Van Hummelen, Jeffrey H. Wisoff, Jay S. Loeffler, Priscilla Kaliopi Brastianos, John H. Shin, Lawrence F. Borges et al. · 2015 · Acta Neuropathologica
BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway
Adam L. Green, John A. DeSisto, Patrick C. Flannery, Rakeb Lemma, Aaron J. Knox, Madeleine E. Lemieux, Bridget L. Sanford, Rebecca O’Rourke, Shakti H Ramkissoon, Kristen L. Jones et al. · 2019 · Oncogene
Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones
Jay F. Sarthy, Michael P. Meers, Derek H. Janssens, Jorja G. Henikoff, Heather M. Feldman, Patrick J. Paddison, Christina M. Lockwood, Nicholas Alexander Vitanza, James M. Olson, Kami Ahmad et al. · 2020 · eLife
Pediatric high‐grade glioma: moving toward subtype‐specific multimodal therapy
Hannah V. Chatwin, Joselyn Cruz Cruz, Adam L. Green · 2021 · FEBS Journal
Common mutations in ALK2/ACVR1, a multi-faceted receptor, have roles in distinct pediatric musculoskeletal and neural orphan disorders
Maurizio Pacifici, Eileen Malko Shore · 2015 · Cytokine & Growth Factor Reviews
Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)
Ho‐Shin Gwak, Hyeon Jin Park · 2017 · Critical Reviews in Oncology/Hematology
Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG
Ilango Balakrishnan, Etienne P. Danis, Angela M. Pierce, Krishna P.C. Madhavan, Dong Wang, Nathan A. Dahl, Bridget L. Sanford, Diane K. Birks, Nate Davidson, Dennis Serge Metselaar et al. · 2020 · Cell Reports
Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic
Andrés Morales La Madrid, Rintaro Hashizume, Mark W. Kieran · 2015 · Frontiers in Oncology
The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma
Hiroaki Miyahara, Sridevi Yadavilli, Manabu Natsumeda, Jeffrey A. Rubens, Louis T. Rodgers, Madhuri Kambhampati, Isabella C. Taylor, Harpreet Kaur, Laura Asnaghi, Charles G. Eberhart et al. · 2017 · Cancer Letters
Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
Wenyong Long, Yi Yang, Shen Chen, Qi Cao, Wei Zhao, Qing Liu · 2017 · Frontiers in Pharmacology
Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma
Maria Tsoli, Jie Liu, Laura Franshaw, Han M. Shen, Cecilia Y. Cheng, MoonSun Jung, Swapna Mahurkar Joshi, Anahid Ehteda, Aaminah Khan, Angel Montero-Carcabosso et al. · 2018 · Oncotarget
A machine learning-based prediction model of H3K27M mutations in brainstem gliomas using conventional MRI and clinical features
Changcun Pan, Jia Liu, Jie Tang, Xin Chen, Chen Fang, Yuliang Wu, Yibo Geng, Cheng Xu, Xinran Zhang, Zhen Wu et al. · 2018 · Radiotherapy and Oncology
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
Chen He, Ke Xu, Xiaoyan Zhu, Paige Selvy Dunphy, Brian L. Gudenas, Wenwei Lin, Nathaniel R. Twarog, Laura D. Hover, Chang-Hyuk Kwon, Lawryn H. Kasper et al. · 2021 · Nature Communications
New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
Davis P. Argersinger, Sarah R. Rivas, Ashish Harish Shah, Sadhana Jackson, John D. Heiss · 2021 · Cancers
Molecular mechanisms and therapeutic targets in pediatric brain tumors
Kun-Wei Liu, Kristian W. Pajtler, Barbara Christine Worst, Stefan Michael Pfister, Robert J. Wechsler‐Reya · 2017 · Science Signaling
Investigation of model stacking for drug sensitivity prediction
Kevin Matlock, Carlos De Niz, Raziur Rahman, Souparno Ghosh, Ranadip Pal · 2018 · BMC Bioinformatics
Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma
Cavan P. Bailey, Mary Figueroa, Achintyan Gangadharan, Yanwen Yang, Megan M. Romero, Bridget A. Kennis, Sridevi Yadavilli, Verlene K. Henry, Tiara L. Collier, Michelle Monje et al. · 2020 · Neuro-Oncology
MRI-guided focused ultrasound enhances drug delivery in experimental diffuse intrinsic pontine glioma
Joji Ishida, Saira B. Alli, Andrew Bondoc, Brian J. Golbourn, Nesrin Sabha, Kristina Mikloska, Stacey L. Krumholtz, Dilakshan Srikanthan, Naohide Fujita, Amanda J. Luck et al. · 2020 · Journal of Controlled Release
Brainstem Glioma in Adults
Jethro Lisien Hu, Stephen Western, Santosh Kesari · 2016 · Frontiers in Oncology
Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model
William Singleton, AM Collins, AS Bienemann, Clare L. Killick-Cole, Harry R. Haynes, Daniel J. Asby, Craig Philip Butts, MJ Wyatt, Neil U. Barua, SS Gill · 2017 · International Journal of Nanomedicine
Diffuse Intrinsic Pontine Glioma : Clinical Features, Molecular Genetics, and Novel Targeted Therapeutics
Ryan Koshy Mathew, James T. Rutka · 2018 · Journal of Korean Neurosurgical Society
Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
Kelly N. Hassell · 2019 · Diseases
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma
Eshini Panditharatna, Joana Graca Marques, Tingjian Wang, Maria C. Trissal, Ilon Liu, Li Jiang, Alexander Beck, Andrew P. Groves, Neekesh V. Dharia, Deyao Li et al. · 2022 · Cancer Discovery
Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models
Marc H.A. Jansen, Tonny Lagerweij, A. Charlotte P. Sewing, Daniëlle J. Vugts, Dannis Gilbert van Vuurden, Carla F.M. Molthoff, Viola Caretti, Susanna J.E. Veringa, Naomi Petersen, Angel Montero Carcaboso et al. · 2016 · Molecular Cancer Therapeutics
Neuronal activity in the glioma microenvironment
Tessa Johung, Michelle Monje · 2017 · Current Opinion in Neurobiology
Diffuse intrinsic pontine glioma: current insights and future directions
Dilakshan Srikanthan, Michael S. Taccone, Randy Van Ommeren, Joji Ishida, Stacey L. Krumholtz, James T. Rutka · 2021 · Chinese Neurosurgical Journal
Adult brainstem gliomas
Sylvia C. Eisele, David A. Reardon · 2016 · Cancer
BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma
Shiva Senthil Kumar, Satarupa Sengupta, Kyungwoo Lee, Nanki Hura, Christine E. Fuller, Mariko Dawn DeWire, Charles B. Stevenson, Maryam Fouladi, Rachid Drissi · 2017 · Oncotarget
Histone H3 Mutations in Cancer
Yi Ching Esther Wan, Jiaxian Liu, Kui Ming Chan · 2018 · Current Pharmacology Reports
Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells
Linda Y. Wu, Uday Bhanu Maachani, Melanie E. Schweitzer, Ranjodh Singh, Melinda Wang, Raymond Y. Chang, Mark M. Souweidane · 2017 · Translational Oncology
Therapeutic Targeting of Histone Modifications in Adult and Pediatric High-Grade Glioma
Maria J. Williams, William Singleton, Stephen P. Lowis, Karim T. A. Malik, Kathreena Mary Kurian · 2017 · Frontiers in Oncology
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors
Satarupa Sengupta, Matthew Sobo, Kyungwoo Lee, Shiva Senthil Kumar, Angela R. White, Ilgen Mender, Christine E. Fuller, Lionel M.L. Chow, Maryam Fouladi, Jerry W. Shay et al. · 2018 · Molecular Cancer Therapeutics
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
Kyle Wierzbicki, Karthik Ravi, Andrea T. Franson, Amy K. Bruzek, Evan Cantor, Micah K. Harris, Morgan J. Homan, Bernard Lawrence Marini, Abed Rahman Kawakibi, Ramya Ravindran et al. · 2020 · Current Oncology Reports
Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
on behalf of the members of the SIOPE DIPG Network, Sophie E. M. Veldhuijzen van Zanten, Joshua Baugh, Brooklyn Chaney, Dennis de Jongh, Esther Sánchez Aliaga, Frederik Barkhof, Johan Noltes, Ruben De Wolf, Jet Van Dijk et al. · 2017 · Journal of Neuro-Oncology
Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes
Yoshua Esquenazi, Nelson S. Moss, Thomas W. Link, Koos E. Hovinga, Anne S. Reiner, Natalie M. DiStefano, Cameron Walter Brennan, Philip H. Gutin, Viviane S. Tabar · 2017 · Neurosurgery
Signal Transduction in Diffuse Intrinsic Pontine Glioma
Ryan J. Duchatel, Evangeline R. Jackson, Frank Alvaro, Brett Nixon, Hubert Hondermarck, Matthew D. Dun · 2019 · PROTEOMICS
Kdm6a suppresses the alternative activation of macrophages and impairs energy expenditure in obesity
Jun Chen, Xing Yue Xu, Yan Li, Li Fan, Jianjun Zhang, Qin Xu, Wantao Chen, Wei Xing Yan, Xu Wang · 2020 · Cell Death and Differentiation
Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children’s Oncology Group report
Jack M. F. Su, Lindsay Baker Kilburn, David B. Mansur, Mark Krailo, Allen B. Buxton, Adesina Adekunle, Amar J. Gajjar, Peter C. Adamson, Brenda J. Weigel, Elizabeth Fox et al. · 2021 · Neuro-Oncology
Actionable Molecular Biomarkers in Primary Brain Tumors
Verena Staedtke, Omar Dildar a Dzaye, Matthias Holdhoff · 2016 · Trends in cancer
Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer
Carl Johannes Koschmann, Felipe Javier Núñez, Flor Mendez, Jacqueline A. Brosnan‐Cashman, Alan Keith Meeker, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2017 · Cancer Research
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
Grant L. Lin, Michelle Monje · 2017 · Journal of Visualized Experiments
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
Michaël Hananja Meel, Mark C. de Gooijer, Dennis Serge Metselaar, A. Charlotte P. Sewing, Kenn Zwaan, Piotr Waranecki, Marjolein Breur, Levi C.M. Buil, Tonny Lagerweij, Laurine E. Wedekind et al. · 2020 · Clinical Cancer Research
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas
Pooja Panwalkar, Benita Tamrazi, Derek Dang, Chan Chung, Stefan R. Sweha, Siva Kumar Natarajan, Matthew J Pun, Jill M. Bayliss, Martin P. Ogrodzinski, Drew W. Pratt et al. · 2021 · Science Translational Medicine
Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
Valentina Di Ruscio, Giada Del Baldo, Francesco Fabozzi, Maria Vinci, Antonella Cacchione, Emmanuel de Billy, Giacomina Megaro, Andrea Carai, Angela Mastronuzzi · 2022 · Diagnostics
Single-cell epigenetic analysis reveals principles of chromatin states in H3.3-K27M gliomas
Nofar Harpaz, Tamir Mittelman, Olga Beresh, Ofir Griess, Noa Furth, Tomer‐Meir Salame, Roni Oren, Liat Fellus‐Alyagor, Alon Harmelin, Sanda Alexandrescu et al. · 2022 · Molecular Cell
PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma
Sabine Mueller, Cassie Kline, Schuyler Stoller, Shannon M. Lundy, Lauren Christopher, Alyssa Terry Reddy, Anu Banerjee, Tabitha M. Cooney, Shannon Raber, Carly Hoffman et al. · 2023 · Neuro-Oncology
Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma
Katherine L. Misuraca, Francisco J. Cordero, Oren Josh Becher · 2015 · Frontiers in Oncology
Epigenetic Targeted Therapy for Diffuse Intrinsic Pontine Glioma
Rintaro Hashizume · 2017 · Neurologia medico-chirurgica
New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis
Alexandre Plessier, Ludivine Le Dret, Pascale Varlet, Kévin Beccaria, Joëlle Lacombe, Sébastien Mériaux, Françoise Geffroy, Laurence Fiette, Patricia Flamant, Fabrice C Chrétien et al. · 2017 · Oncotarget
The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells
Aixia Sui, Xu Yongbing, Yitong Li, Qilu Hu, Zeyang Wang, Hongtao Zhang, Junjie Yang, Xiaoqiang Guo, Wenqing Zhao · 2017 · Oncotarget
A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4
Erik Abraham Williams, Priscilla Kaliopi Brastianos, Hiroaki Wakimoto, Amir Zolal, Mariella G. Filbin, Daniel P. Cahill, Sandro Santagata, Tareq Adnan Juratli · 2023 · Acta Neuropathologica
Exosomal circRNA BTG2 derived from RBP-J overexpressed-macrophages inhibits glioma progression via miR-25-3p/PTEN
Lei Shi, Ying Cao, Wei Yuan, Jun Kang Guo, Guan Sun · 2022 · Cell Death and Disease
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003
Cassie Kline, Payal Jain, Lindsay Baker Kilburn, Erin R. Bonner, Nalin M. Gupta, John Ross Crawford, Anu Banerjee, Roger J. Packer, Javier E. Villanueva-Meyer, Tracy L. Luks et al. · 2022 · Clinical Cancer Research
Diffuse Intrinsic Pontine Glioma (DIPG): Breakthrough and Clinical Perspective
Maria Grazia Perrone, Antonio Ruggiero, Antonella Centonze, Antonio Carrieri, Savina Ferorelli, Antonio Scilimati · 2020 · Current Medicinal Chemistry
Repurposing Vandetanib plus Everolimus for the Treatment of ACVR1 -Mutant Diffuse Intrinsic Pontine Glioma
Diana M. Carvalho, Peter J. Richardson, Nagore Olaciregui, Reda Stankunaite, Cinzia Emilia Lavarino, Valeria Molinari, Elizabeth A. Corley, Daniel P. Smith, Ruth R. Ruddle, Adam Donovan et al. · 2021 · Cancer Discovery
Developmental origins and oncogenic pathways in malignant brain tumors
Qing Richard Lu, Lily Qian, Xianyao Zhou · 2019 · Wiley Interdisciplinary Reviews Developmental Biology
Algorithms for Drug Sensitivity Prediction
Carlos De Niz, Raziur Rahman, Xiangyuan Zhao, Ranadip Pal · 2016 · Algorithms
Reciprocal H3.3 gene editing identifies K27M and G34R mechanisms in pediatric glioma including NOTCH signaling
Kuang-Yui Michael Chen, Kelly M. Bush, Rachel Herndon Klein, Vanessa Cervantes, Nichole Lewis, Aasim Naqvi, Angel Montero Carcaboso, Mirna Lechpammer, Paul S. Knoepfler · 2020 · Communications Biology
Splicing is an alternate oncogenic pathway activation mechanism in glioma
Robert Siddaway, Scott Milos, Arun Kumaran Anguraj Vadivel, Tara Dobson, Jyothishmathi Swaminathan, Scott T. Ryall, Sanja Pajovic, Palak G. Patel, Javad Nazarian, Oren Josh Becher et al. · 2022 · Nature Communications
H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape
Noa Furth, Danielle Algranati, Bareket Dassa, Olga Beresh, Vadim Fedyuk, Natasha Morris, Lawryn H. Kasper, Daniel R. Jones, Michelle Monje, Suzanne J. Baker et al. · 2022 · Cell Reports
Context-dependent tumor-suppressive BMP signaling in diffuse intrinsic pontine glioma regulates stemness through epigenetic regulation of CXXC5
Ye Sun, Kun Huang Yan, Yi Wang, Cheng Xu, Dan Wang, Wei Zhong Zhou, Shuning Guo, Yujie Han, Lei Tang, Yanqiu Shao et al. · 2022 · Nature Cancer
Open Access Chemical Probes for Epigenetic Targets
Peter J. Brown, Susanne Müller · 2015 · Future Medicinal Chemistry
Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high‐grade and diffuse intrinsic pontine glioma
Alberto Broniscer, Sujuan Jia, Belinda Neal Mandrell, Dima Hamideh, Jie Huang, Arzu Onar‐Thomas, Amar J. Gajjar, Susana Catalina Raimondi, Ruth Tatevossian, Clinton F. Stewart · 2018 · Pediatric Blood & Cancer
Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma
Thomas Alexander Kluiver, María Alieva, Dannis Gilbert van Vuurden, Ellen J. Wehrens, Anne C. Rios · 2020 · Frontiers in Oncology
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG
Anahid Ehteda, Sandy Simon, Laura Franshaw, Federico Manuel Giorgi, Jie Liu, Swapna Mahurkar Joshi, Jourdin R.C. Rouaen, Chi Nam Ignatius Pang, Ruby Pandher, Chelsea Mayoh et al. · 2021 · Cell Reports
Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials
Sudarshawn N. Damodharan, Montserrat A. Lara-Velazquez, Brooke Carmen Williamsen, Jeffrey J. Helgager, Mahua Dey · 2022 · Journal of Personalized Medicine
Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies
Eléonore Maury, Rintaro Hashizume · 2017 · Epigenetics
Emerging roles of telomeric chromatin alterations in cancer
Stefano Cacchione, Annamaria Biroccio, Angela Rizzo · 2019 · Journal of Experimental & Clinical Cancer Research
Panobinostat sensitizes KRAS‐mutant non‐small‐cell lung cancer to gefitinib by targeting TAZ
Wen‐Ying Lee, Pin‐Cyuan Chen, Wen‐Shin Wu, Han‐Chung Wu, Chun-Hsin Lan, Yen‐Hua Huang, Chia‐Hsiung Cheng, Ku‐Chung Chen, Cheng‐Wei Lin · 2017 · International Journal of Cancer
Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma
Hueng‐Chuen Fan, Chuan‐Mu Chen, Ching-Shiang Chi, Jeng‐Dau Tsai, Kuo-Liang Chiang, Yu‐Kang Chang, Shinn‐Zong Lin, Horng‐Jyh Harn · 2019 · International Journal of Molecular Sciences
Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss
Dylan M. Marchione, Amanda Lisby, Angela Nicole Viaene, Mariarita Santi, MacLean Nasrallah, Liping Wang, Erik Abraham Williams, Ana Belén Larque, Ivan A. Chebib, Benjamin Aaron Garcia et al. · 2019 · Modern Pathology
Frame-based stereotactic biopsy of deep-seated and midline structures in 511 procedures: feasibility, risk profile, and diagnostic yield
Christina Hamisch, Jana Minartz, Tobias Blau, Vanessa Hafkemeyer, Daniel F. Ruess, Alexandra Hellerbach, Stefan Josef Grau, Maximilian Ingolf Ruge · 2019 · Acta Neurochirurgica
MRI-guided focused ultrasound blood–brain barrier opening increases drug delivery and efficacy in a diffuse midline glioma mouse model
Payton J. Martinez, Genna Nault, Jenna Steiner, Michael F. Wempe, Angela M. Pierce, Breauna Brunt, Mathew Slade, Jane J. Song, Andrew Mongin, Kang-Ho Song et al. · 2023 · Neuro-Oncology Advances
Diffuse Intrinsic Pontine Glioma
Tammy Hennika, Oren Josh Becher · 2015 · Journal of Child Neurology
Diffuse midline glioma: review of epigenetics
Tabitha M. Cooney, Evan Lubanszky, Rachna Prasad, Cynthia E Hawkins, Sabine Mueller · 2020 · Journal of Neuro-Oncology
Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4
Yan Mo, Shoufu Duan, Xu Zhang, Xu Hua, Hui Zhou, Hong-Jian Wei, Jun Watanabe, Nicholas McQuillan, Zhenyi Su, Wei Jun Gu et al. · 2022 · Cancer Discovery
Gliomas Genomics and Epigenomics: Arriving at the Start and Knowing It for the First Time
Mariella G. Filbin, Mario L. Suvà · 2016 · Annual Review of Pathology Mechanisms of Disease
New Directions in the Treatment of Glioblastoma
Zachary J. Reitman, Frank Winkler, Andrew E. H. Elia · 2018 · Seminars in Neurology
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
Hideaki Abe, Manabu Natsumeda, Yu Kanemaru, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, Junichi Yoshimura, Makoto Oishi, Yukihiko Fujii · 2018 · Neurologia medico-chirurgica
Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease
Jin Qi, Darian R. Esfahani, T. Huang, Patrick A. Ozark, Elizabeth T. Bartom, Rintaro Hashizume, Erin R. Bonner, S. An, Craig Horbinski, Charles David James et al. · 2019 · Acta Neuropathologica Communications
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
Luke J. Weisbrod, Thiraviyam Anand, Raghupathy Vengoji, Nicole Shonka, Maneesh Jain, Winson S. Ho, Surinder K. Batra, Afshin Salehi · 2024 · Cancer Letters
AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models
Edwin Chang, Christoph Pohling, Arutselvan Natarajan, Timothy Howard Witney, Jasdeep Kaur, Lingyun Xu, Gayatri Gowrishankar, Aloma L. D’Souza, Surya Murty, Sophie Schick et al. · 2015 · Journal of Neuro-Oncology
MELK Inhibition in Diffuse Intrinsic Pontine Glioma
Michaël Hananja Meel, Mark C. de Gooijer, Míriam Guillén Navarro, Piotr Waranecki, Marjolein Breur, Levi C.M. Buil, Laurine E. Wedekind, Jos W. R. Twisk, Jan Köster, Rintaro Hashizume et al. · 2018 · Clinical Cancer Research
Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
Wei Meng, Baocheng Wang, Weiwei Mao, Jiajia Wang, Zhao Yang, Qifeng Li, Chenran Zhang, Yujie Tang, Jie Ma · 2018 · Journal of Experimental & Clinical Cancer Research
MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study
Lydia T. Tam, Kristen W. Yeom, Jason N. Wright, Alok I Jaju, Alireza Radmanesh, Michelle Han, Sebastian Miguel Toescu, Maryam Maleki, Eric Chen, Andrew Campion et al. · 2021 · Neuro-Oncology Advances
Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
Elisha Hayden, Holly Holliday, Rebecca J. Lehmann, Aaminah Khan, Maria Tsoli, Benjamin S. Rayner, David Simon Ziegler · 2021 · Cancers
Oncohistones: Hijacking the Histone Code
Varun Sahu, Chao Lü · 2022 · Annual Review of Cancer Biology
The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children
Julieann C. Lee, David A. Solomon, Tarık Tihan · 2017 · Journal of Neuro-Oncology
Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors
Cheng Xu, Xiaoqing Liu, Yibo Geng, Qing‐Ran Bai, Changcun Pan, Yu Sun, Xin Chen, Hai Yu, Yuliang Wu, Peng Zhang et al. · 2017 · Oncotarget
Pediatric Brain Tumors
Mai T. Dang, Peter C. Phillips∥ · 2017 · CONTINUUM Lifelong Learning in Neurology
Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma
Nathan A. Dahl, Etienne P. Danis, Ilango Balakrishnan, Dong Wang, Angela M. Pierce, Faye M. Walker, Ahmed Gilani, Natalie Julie Serkova, Krishna P.C. Madhavan, Susan P. Fosmire et al. · 2020 · Cell Reports
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
Alexandre Perla, Lívia Fratini, Paula Schoproni Cardoso, Carolina Nör, Andre Tesainer Brunetto, Algemir Lunardi Brunetto, Caroline Brunetto de Farias, Mariane da Cunha Jaeger, Rafael Roesler · 2020 · Frontiers in Cell and Developmental Biology
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas
Stefan R. Sweha, Chan Chung, Siva Kumar Natarajan, Pooja Panwalkar, Matthew J Pun, Amer Ghali, Jill M. Bayliss, Drew W. Pratt, Anand Shankar, Visweswaran Ravikumar et al. · 2021 · Science Translational Medicine
A nomogram strategy for identifying the subclassification of IDH mutation and ATRX expression loss in lower-grade gliomas
Shiman Wu, Xi Zhang, Wenting Rui, Yaru Sheng, Yu Yang, Yong Zhang, Zhenwei Yao, Tianming Qiu, Yan Ren · 2022 · European Radiology
Histone deacetylase inhibitor panobinostat potentiates the anti-cancer effects of mesenchymal stem cell-based sTRAIL gene therapy against malignant glioma
Seung Ah Choi, Chanhee Lee, Pil Ae Kwak, Chul‐Kee Park, Kyu‐Chang Wang, Ji Hoon Phi, Ji Yeoun Lee, Sangjoon Chong, Seung‐Ki Kim · 2018 · Cancer Letters
H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines
Andria Rakotomalala, Quentin Bailleul, Clara Savary, Mélanie Arcicasa, Maud Hamadou, Paul Huchedé, Audrey Hochart, Audrey Restouin, Rémy Castellano, Yves Collette et al. · 2021 · Cancers
Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
Aimée du Chatinier, Michaël Hananja Meel, Arvid I Das, Dennis Serge Metselaar, Piotr Waranecki, Marianna Bugiani, Marjolein Breur, Erin F. Simonds, Edbert D Lu, William A. Weiss et al. · 2022 · Neuro-Oncology Advances
Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields
Chang, Edwin, Pohling, Christoph, Beygui, Nooshin, Patel, Chirag B., Rosenberg, Jarrett, Ha, Dong Ho, Gambhir, Sanjiv S. · 2017 · Journal of Neuro-Oncology
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma
Daniel J. Laverty, Shiv Kumar Gupta, Gary Andrew Bradshaw, Alexander S. Hunter, Brett L. Carlson, Nery Matias Calmo, Jiajia Chen, Shulan Tian, Jann Nagina Sarkaria, Zachary David Nagel · 2024 · Nature Communications
The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease
Joshua Baugh, Ute Katharina Bartels, James L. Leach, Blaise V. Jones, Brooklyn Chaney, Katherine E. Warren, Jenavieve Kirkendall, Renee Doughman, Cynthia E Hawkins, Lili Miles et al. · 2017 · Journal of Neuro-Oncology